Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone vs butorphanol effects on gut microbiota in non-ventilated ICU patients
ChiCTR2500109551Phase 4Not yet recruiting
- Sponsor
- Baiyun District People's Hospital of Guangzhou
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone and butorphanol (2 arms), sponsored by Baiyun District People's Hospital of Guangzhou. Primary endpoint: Intestinal flora structure and diversity. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
hydromorphonebutorphanol
Beyond the preview
Go deeper on ChiCTR2500109551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109551.